🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Miriam N. Lango

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-0736-7473

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).”.

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6500

N/A

0.694DataRank · unranked

101 citations

Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra +15 more

Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6077

N/A

0.385DataRank · unranked

12 citations

Yael Flamand, Harry Quon, Joaquín J. García, Gregory S. Weinstein, Umamaheswar Duvvuri +12 more

Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis

Otolaryngology(2024)10.1002/ohn.672

N/A

0.385DataRank · unranked

12 citations

Amy C. Moreno, Yun Qing, J. Jack Lee, Faye M. Johnson, Miriam N. Lango +10 more

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6036

N/A

0.165DataRank · unranked

2 citations

Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García +11 more

Heat and moisture exchanger cassettes: Results of a quality/safety initiative to reduce postoperative mucus plugging after total laryngectomy

Head & Neck(2020)10.1002/hed.26267

N/A

0DataRank · unranked

19 citations

Kathleen Moran, Jiangtao Gou, John A. Ridge, Linda Schiech, Jeffrey Liu +2 more

Designing an Electronic Patient-Reported Outcomes Information Infrastructure Supported by the RE-AIM Implementation Framework

Advances in Cancer Education and Quality Improvement(2025)10.52519/aceqi.25.1.2.a6

N/A

0DataRank · unranked

1 citations

Angela Peek, Toshiko S. Shein, Kevin R. Shook, Sara M. Ali, Laia Humbert‐Vidan +13 more

Depletion of effector regulatory T cells drives major response to induction dual immune checkpoint blockade

medRxiv(2024)10.1101/2024.01.04.23300616

N/A

0DataRank · unranked

0 citations

Nils-Petter Rudqvist, Bo Jiang, Shengbin Ye, Shan He, Qingnan Liang +25 more

Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1390

N/A

0DataRank · unranked

14 citations

Nils-Petter Rudqvist, Bo Jiang, Shengbin Ye, Shan He, Qingnan Liang +26 more

International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter‐observer performance evaluation

Cancer(2025)10.1002/cncr.35815

N/A

0DataRank · unranked

6 citations

Serageldin Kamel, Kareem A. Wahid, Cem Dede, Nicolette Taku, Renjie He +42 more